DORAL
- Product NDC
- 61825-165
- 11-digit product format
- 618250165
- Labeler code
- 61825
- Product ID
- 61825-165_f188f06d-0e1e-21c0-e053-2a95a90a7ffc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Quazepam
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Galt Pharmaceuticals, LLC
- Application
- NDA018708
- Marketing category
- NDA
- Marketing start
- 2017-07-19
- Marketing end
- 0000-00-00
- Substance
- QUAZEPAM
- Active strength
- 15 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61825-165-10 | 61825016510 | 100 TABLET in 1 BOTTLE (61825-165-10) | 100 tablet | 2017-07-19 | 0000-00-00 | No | No | Current |
| 61825-165-30 | 61825016530 | 30 TABLET in 1 BOTTLE (61825-165-30) | 30 tablet | 2018-12-04 | 0000-00-00 | No | No | Current |